<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23454317-ADC4-4369-A212-BF0802191E59"><gtr:id>23454317-ADC4-4369-A212-BF0802191E59</gtr:id><gtr:name>Domainex</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/644951E7-60A3-4B58-9FBD-8042BE5C5FED"><gtr:id>644951E7-60A3-4B58-9FBD-8042BE5C5FED</gtr:id><gtr:name>Institute of chemical technology</gtr:name><gtr:address><gtr:line1>Institute of Chemical Technology</gtr:line1><gtr:line2>Nathalal Parekh Marg</gtr:line2><gtr:line3>Matunga</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64290A8C-25CA-4874-9DC4-6EBCDD0E157B"><gtr:id>64290A8C-25CA-4874-9DC4-6EBCDD0E157B</gtr:id><gtr:name>Universiti Putra Malaysia</gtr:name><gtr:address><gtr:line1>43400 UPM Serdang</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EAF17943-4FDF-4E08-A8D2-281D7130987C"><gtr:id>EAF17943-4FDF-4E08-A8D2-281D7130987C</gtr:id><gtr:name>Birkbeck, University of London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3E18DACB-05AA-4C71-88FB-C909A8311BB5"><gtr:id>3E18DACB-05AA-4C71-88FB-C909A8311BB5</gtr:id><gtr:name>Birkbeck College</gtr:name><gtr:department>Biological Sciences</gtr:department><gtr:address><gtr:line1>Malet Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3E18DACB-05AA-4C71-88FB-C909A8311BB5"><gtr:id>3E18DACB-05AA-4C71-88FB-C909A8311BB5</gtr:id><gtr:name>Birkbeck College</gtr:name><gtr:address><gtr:line1>Malet Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23454317-ADC4-4369-A212-BF0802191E59"><gtr:id>23454317-ADC4-4369-A212-BF0802191E59</gtr:id><gtr:name>Domainex</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/644951E7-60A3-4B58-9FBD-8042BE5C5FED"><gtr:id>644951E7-60A3-4B58-9FBD-8042BE5C5FED</gtr:id><gtr:name>Institute of chemical technology</gtr:name><gtr:address><gtr:line1>Institute of Chemical Technology</gtr:line1><gtr:line2>Nathalal Parekh Marg</gtr:line2><gtr:line3>Matunga</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64290A8C-25CA-4874-9DC4-6EBCDD0E157B"><gtr:id>64290A8C-25CA-4874-9DC4-6EBCDD0E157B</gtr:id><gtr:name>Universiti Putra Malaysia</gtr:name><gtr:address><gtr:line1>43400 UPM Serdang</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAF17943-4FDF-4E08-A8D2-281D7130987C"><gtr:id>EAF17943-4FDF-4E08-A8D2-281D7130987C</gtr:id><gtr:name>Birkbeck, University of London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7F688C64-0271-459E-9626-85470DAAC64B"><gtr:id>7F688C64-0271-459E-9626-85470DAAC64B</gtr:id><gtr:firstName>Sanjib</gtr:firstName><gtr:surname>Bhakta</gtr:surname><gtr:orcidId>0000-0002-1165-9295</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801956"><gtr:id>BF0625A0-BAF9-4DBC-81E1-9E4A1F2CE5CE</gtr:id><gtr:title>ATP-dependent Mur ligases in Mycobacterium tuberculosis: search for potential therapeutic targets against Tuberculosis.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801956</gtr:grantReference><gtr:abstractText>Tuberculosis (TB) a contagious disease caused by the ?Superbug? Mycobacterium tuberculosis, remains the leading cause of death worldwide. 

Despite the presence of chemotherapy, extensive rise in antibiotic resistance is a cause of concern around the world, including the UK. In a reported case of extreme drug resistance (XDR) there is no new drug available that can combat the disease. Hence there is an urgent need for new drug development. 

A key feature of Mycobacterium tuberculosis is the unique cell wall of consisting of three major layers - peptidoglycan, arabinogalactan and mycolic acid covalently linked. The cell wall architecture and presence of ?peptidoglycans?, not only helps in maintaining the shape and size of the bacterial cell, but also protects the bacteria from toxic radicals, osmotic lysis, and foreign attack. 

Thus the crucial nature of the protective cell wall-peptidoglycan in M. tuberculosis should be exploited for new drug discovery against TB. Characterisation of the peptidoglycan biosynthesis will help in identification of potential targets for new drugs.

The proposed study aims to identify those cellular components (enzymes) that are vital to the production of this protective cell wall, and thus essential for the survival of the TB-bacteria. We will be investigating, in detail, the structural and functional dynamics of the enzymes that play major roles in the peptidoglycan biosynthesis. In addition, we will also modify these vitally important TB enzymes and observe how the TB-Superbugs survive.</gtr:abstractText><gtr:technicalSummary>The recurrence of Tuberculosis (TB) as a global health emergency has highlighted the urgent need for new therapeutic targets to facilitate the development of new drugs against the disease. TB is caused by the micro-organism Mycobacterium tuberculosis which is a member of the order Actinomycetales. A key common feature of this order is their complex cell walls, which consist of an unusual mycolyl-arabinogalactan-peptidoglycan (mAGP) complex. Within the cell wall, peptidoglycan not only provides shape and structural integrity to the bacterial cell, but also plays a critical role in protecting the bacteria against osmotic lysis and hydrolytic enzymes produced by host defence mechanisms. Mycobacterium tuberculosis is unique in its peptidoglycan architecture indicating that the enzymes regulating the synthesis of the pivotal substrates are novel therapeutic targets.

UDP-N-acetylmuramoyl-tripeptide ligase (MurE) is a member of the ATP-dependent ligase family and incorporates different amino acids including meso-diaminopimelate into peptidoglycan during synthesis in a species-specific manner. In addition, MurF acts at the final stage of UDP sugar linked polypeptide synthesis. The product of this reaction, UDP N-acetyl muramoyl pentapeptide, is the key substrate for the membrane bound transition stage of peptidoglycan biosynthesis. Due to the multi-facetted nature of the functional implications of ATP-dependent ligases, it provides a possible vulnerability that can be exploited. MurE and MurF are coded for in the M. tuberculosis genome by a single copy of the gene. This decreases the possibility that any disruption of the MurE and/or MurF protein will be compensated for by an alternative biochemical pathway. Moreover, these enzymes do not have human homologues. The combinations of these features make ATP-dependent ligases excellent candidates for the identification of novel therapeutic drug targets. 

These two biochemical steps are pivotal for endogenous peptidoglycan biosynthesis pathways. Our knowledge is limited in these central biochemical reactions of Mycobacterium tuberculosis, the enzymes involved in these reaction steps and their regulation, on the cell function and physiology of the unique genus. We propose to elucidate the structure and function of the enzymes involved in the series of functionally linked ATP dependant ligation reactions in Mycobacterium tuberculosis, which are potential drug targets for combating TB.</gtr:technicalSummary><gtr:fund><gtr:end>2013-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>475560</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>a short film was produced and launched at the World TB Summit in London to commemorate the World TB Day in 2014</gtr:description><gtr:id>07677AB7-0B66-4281-802F-AB172C4AC03B</gtr:id><gtr:impact>enhanced public engagement and understanding in TB control, education and laboratory research.</gtr:impact><gtr:outcomeId>5460b3b633bf84.92955975</gtr:outcomeId><gtr:title>A short film launched to commemorate World TB Day</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://www.youtube.com/watch?v=gvvvTM__GFI</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birkbeck, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biological Sciences</gtr:department><gtr:description>Structural Biology, Birkbeck</gtr:description><gtr:id>D5F9BE1E-C9A6-4D40-B70B-4956ED1B3BAF</gtr:id><gtr:impact>An interdisciplinary collaboration in between Structural Biology and Molecular Microbiology:

Original Research Articles:
1. Basavannacharya, C., Robertson, G., Munshi, T., Keep, N.H. &amp;amp; Bhakta, S. (2010). ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation. Tuberculosis (Edinb) 90(1), 16-24. 

2. Basavannacharya, C., Moody, P. R., Munshi, T., Cronin, N., Keep, N. H. &amp;amp; Bhakta, S. (2010). Roles of amino acid residues essential for the enzyme activity of MurE of Mycobacterium tuberculosis identified. Protein &amp;amp; Cell 1(10)(accepted in press; featured as cover page article) 

3. Evangelopoulos D, Cronin N, Daviter T, Sim E, Keep NH and Bhakta S. (2011) Characterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatis. FEBS J. 278(24):4824-32. 

4. Munshi, T.; Gupta, A.; Guzman, J. D.; Evangelopoulos, D.; Gibbons, S.; Keep, N.H. and Bhakta, S.* (2013) Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis.
PloS ONE 8(3): e60143. doi:10.1371/journal.pone.0060143</gtr:impact><gtr:outcomeId>NamoyEK77rt-1</gtr:outcomeId><gtr:partnerContribution>Training and advice on setting crystallisation trials and solving X-Ray diffraction data for 3D structural elucidation of mycobacterial proteins</gtr:partnerContribution><gtr:piContribution>significant intellectual input into our common research interest in cell wall peptidoglycan biosynthesis, degradation and recycling in Mycobacterium tuberculosis; Supervised three PhD Students (awarded PhDs in between 2010 and 2013) worked on structural and functional characterisation of mycobacterial proteins. Generated four original research articles and a few others are in preparation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Chemical Technology (ICT)</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>NCEs and new formulations to tackle MDR-TB_India</gtr:description><gtr:id>FB0A5702-3F07-4699-9061-79380174DBC7</gtr:id><gtr:impact>An interdisciplinary collaboration between pharmaceutical science and molecular microbiology &amp;amp; biochemistry. A joint split-site commonwealth proposal application is currently under review.</gtr:impact><gtr:outcomeId>5460965ef254f2.62856004-1</gtr:outcomeId><gtr:partnerContribution>Generated novel chemical entities and pharmaceutical formulations for testing their anti-TB properties and investigating modes of action</gtr:partnerContribution><gtr:piContribution>Comprehensive evaluation of biological properties of pure natural product compounds against whole mycobacterial cell, drug efflux mechanisms and biofilm formation as well as against the target enzymes (such as ATP dependent mur ligases, Muerin peptide ligase, Arylamine N-acetyltransferase, Oxidoreductases from M. tuberculosis).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Inhibitors of Cell wall PG (Med Chem)</gtr:description><gtr:id>E8DBC24D-6C39-480D-A9FC-E6D52E6B79DE</gtr:id><gtr:impact>An interdisciplinary collaboration in between medicinal chemistry, molecular microbiology and chemical biology. Resulted in successful joint supervision of one PhD student, two post-graduate project students, three original research articles and a joint patent application.</gtr:impact><gtr:outcomeId>UAiZjeH81sn-1</gtr:outcomeId><gtr:partnerContribution>Synthesized novel derivatives (more than 100) of aporphine alkaloids as antituberculars.</gtr:partnerContribution><gtr:piContribution>evaluation of the biological properties of the novel compounds against the whole mycobacterial cell as well as against the target enzymes (ATP dependent mur ligases). Currently supervising an interdisciplinary PhD student. A joint UK patent application and an original research article are under review.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Durham University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>New antituberculars with novel MoA_Durham</gtr:description><gtr:id>53FED7A0-D4FF-4FCC-9BE6-A70DE4173374</gtr:id><gtr:impact>An interdisciplinary academic research collaboration (Natural Product Chemistry, Computational Biology &amp;amp; Molecular Microbiology) generated original research articles and a successful small research grant. One review article is currently in preparation 

Original Research Articles:
1. Kottakota SK, Benton M, Evangelopoulos D, Guzman JD, Bhakta S, McHugh TD, Gray M, Groundwater PW, Marrs EC, Perry JD and Harburn JJ. (2012) Versatile routes to marine sponge metabolites through benzylidene rhodanines. Org Lett.;14(24):6310-3. 

2. Kottakota, S.K.; Evangelopoulos, D.; Alnimr, A.; Bhakta, S.; McHugh, T.D.; Gray, M.; Groundwater, P.W.; Marrs, E.C.L.; Perry, J.D.; Spilling, C.D. and Harburn, J.J. (2012) Synthesis and biological evaluation of Purpurealidin E-derived marine sponge metabolites: Aplysamine-2, Aplyzanzine A, Suberedamines A,B and Anomoian A. J. Nat Prod. 75(6):1090-101.</gtr:impact><gtr:outcomeId>5460925f448cc0.53937790-1</gtr:outcomeId><gtr:partnerContribution>Extract, fractionate, purify, semi-synthesize as well as design natural product inhibitors against target enzymes as well as against whole cell phenotype for validation.</gtr:partnerContribution><gtr:piContribution>Comprehensive evaluation of the biological properties of pure natural product compounds against the whole mycobacterial cell, drug efflux mechanisms and biofilm formation as well as against the target enzymes (ATP dependent mur ligases, N-acetyl transferase, Oxido-reductases). Generated three joint research publications. One review article and a few other research articles are in preparation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Domainex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Industrial co-operation_Domainex</gtr:description><gtr:id>2A73A5EE-A0E5-4F4D-A134-062190651728</gtr:id><gtr:impact>This academic-industrial partnership is interdisciplinary and complementary.</gtr:impact><gtr:outcomeId>54608db32694e2.44107485-1</gtr:outcomeId><gtr:partnerContribution>Design specific inhibitors of the ATP-dependent MurE ligase in M. tuberculosis.</gtr:partnerContribution><gtr:piContribution>A high-throughput assay available for evaluation of compounds against ATP-dependent Mur Ligases and Murein Peptide Ligase in Mycobacterium tuberculosis.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Substrates and analogues of cellwall-PG enzymes</gtr:description><gtr:id>C1848A8A-5E3A-493F-B0B1-FE12B71F5B6E</gtr:id><gtr:impact>An interdisciplinary collaboration in between synthetic chemistry and molecular microbiology. A PhD student is currently under joint supervision and generated one review article and one research article currently in preparation.</gtr:impact><gtr:outcomeId>nBcse3XCEBe-1</gtr:outcomeId><gtr:partnerContribution>Synthesizing substrates and substrate analogues (using solid phase peptide synthesis)</gtr:partnerContribution><gtr:piContribution>assaying the activity and inhibition of substrates and substrate analogues against ATP-dependent Mur ligases and Murein peptide ligases from bacteria.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Natural Product Chemistry UCL-SOP</gtr:description><gtr:id>6D2B6164-B97B-46A5-8DAF-458460817A33</gtr:id><gtr:impact>An interdisciplinary collaboration in between natural product chemistry, medicinal chemistry and molecular microbiology:

Original research articles:
1. Guzman, J.D.; Mortazavi, P.N.; Munshi, T.; Evangelopoulos, D.; McHugh, T.D.; Gibbons, S.; Malkinson, J. and Bhakta, S. (2014) 2-Hydroxy-substituted cinnamic acids and acetanilides are selective growth inhibitors of Mycobacterium tuberculosis. ChemMedComm 5 (1) 47 - 50.

2. Shiu WK, Malkinson JP, Rahman MM, Curry J, Stapleton P, Gunaratnam M, Neidle S, Mushtaq S, Warner M, Livermore DM, Evangelopoulos D, Basavannacharya C, Bhakta, S., Schindler BD, Seo SM, Coleman D, Kaatz GW, Gibbons S. (2013) A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. Int J Antimicrob Agents. 42(6):513-8. 

3. Guzman JD, Evangelopoulos D, Gupta A, Birchall K, Mwaigwisya S, Saxty B, McHugh TD, Gibbons S, Malkinson J, Bhakta S.* (2013) Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open, 3(6). 

4. Guzman JD, Evangelopoulos D, Gupta A, Prieto JM, Gibbons S. and Bhakta S. (2013) Antimycobacterials from Lovage Root (Ligusticum officinale Koch). Phytotherapy Research, 27(7):993-8.

5. Wube, A.; Guzman, J.D.; H&amp;uuml;fner, A.; Hochfellner, C.; Blunder, M.; Bauer, R.; Gibbons, S.; Bhakta, S. and Bucar, F. (2012) Synthesis and biological evaluation of a new series of N-alkyl-2-alkynyl-4-(1H)-quinolones. Molecules 17(7):8217-40.1. 

6. Osman, K., Evangelopoulos, D., Basavannacharya, C., Gupta, A., McHugh, T.D., Bhakta, S. and Gibbons, S. (2012) An antibacterial from Hypericum acmosepalum inhibits ATP dependent MurE ligase from Mycobacterium tuberculosis. Int. J. Antimicrob. Agents. 39(2):124-9.

7. Guzman, J.D., Wube, A., Evangelopoulos, D., Gupta, A., H&amp;uuml;fner, A., Basavannacharya, C., Rahman, M.M., Thomaschitz, C., Bauer, R., McHugh, T.D., Nobeli, I., Prieto, J.M., Gibbons, S., Bucar, F.&amp;para; and Bhakta, S.&amp;para;* (2011) Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. J. Antimicrob. Chemotherapy 66(8):1766-72. (&amp;para; equal contribution).

8. Guzman, J.D.; Gupta, A.; Evangelopoulos, D.; Basavannacharya, C.; Pabon, L.C.; Plazas, E.A.; Mu&amp;ntilde;oz, D.R.; Delgado, W.A.; Cuca, L.E.; Ribon, W.; Gibbons, S. and Bhakta, S.* (2010) Anti-tubercular screening of natural products from Colombian plants: 3-5 methoxy nordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. J. Antimicrob. Chemotherapy 65(10), 2101-7.

9. O'Donnell, G., Poeschl, R., Zimhony, O., Gunaratnam, M., Moreira, J.B., Neidle, S., Evangelopoulos, D., Bhakta, S., Malkinson, J.P., Boshoff, H.I., Lenaerts, A. &amp;amp; Gibbons, S. (2009). Bioactive pyridine-N-oxide disulfides from Allium stipitatum. J Nat Prod. 72(3), 360-5. 

Review Article:

1. Guzman, J.D.; Gupta, A.; Bucar, F.; Gibbons, S. and Bhakta, S. (2012) Anti-mycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds. Frontiers in Bioscience 17, 1861-1881.</gtr:impact><gtr:outcomeId>KzymBipZKDL-1</gtr:outcomeId><gtr:partnerContribution>training and advice on extraction, purification and charaterisation of natural products. Contributing to a library of natural products inhibitors for a comprehensive biological evaluation.</gtr:partnerContribution><gtr:piContribution>evaluation of the biological properties of the crude extracts, partially purified fractions, pure natural product compounds against the whole mycobacterial cell as well as against the target enzymes (ATP dependent mur ligases). Jointly supervised two interdisciplinary Bloomsbury PhD students and currently supervising two international (Govt funded) PhD students. Generated 9 joint original research publications, 1 review article and a few others under preparation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics</gtr:department><gtr:description>Traditional herbs and new antibiotic_Strathclyde</gtr:description><gtr:id>6B6304EA-DB70-4301-B1C7-14879EBBEEE0</gtr:id><gtr:impact>This is an interdisciplinary collaboration between traditional herbal natural products and microbiology.
Generated one original research article and one article in preparation. In addition, a joint cross-council research grant application (submitted and under review).
Original Research Article:
1. Zhao J, Evangelopoulos D, Bhakta S, Gray AI and Seidel V. (2014) Antitubercular activity of Arctium lappa and Tussilago farfara extracts and constituents. J Ethnopharmacol.;155(1):796-800.</gtr:impact><gtr:outcomeId>54609ca78da586.00550286-1</gtr:outcomeId><gtr:partnerContribution>provide natural product inhibitors (crude extracts , partially purified fractions and pure compounds) for bioassay guided evaluation against a panel of bacterial pathogens.</gtr:partnerContribution><gtr:piContribution>Bioassay guided whole-cell phenotypic and genotypic evaluation of natural products (crude extracts, partially purified fractions and purified molecules).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birkbeck, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biological Sciences</gtr:department><gtr:description>Computational Biology (Bioinformatics), ISMB</gtr:description><gtr:id>322ECE61-A9EF-47C1-848F-2A89EF2B40DA</gtr:id><gtr:impact>An interdisciplinary collaboration between computational biology and molecular microbiology generated an original research article (published):

Guzman. J-D.; Wube, A.; Evangelopoulos, D.; Gupta, A.; H&amp;uuml;fner, A.; Basavannacharya, C.; Raman, M. M.; Thomaschitz, C.; Bauer, R.; McHugh, T.D.; Nobeli, I.; Prieto, J. M.; Gibbons, S.; Bucar, F.; and Bhakta, S. (2011) Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. J. Antimicrob. Chemotherapy 66(8):1766-72.</gtr:impact><gtr:outcomeId>DserKQTfrTm-1</gtr:outcomeId><gtr:partnerContribution>Supervised a PhD student in my group on molecular docking of M. tuberculosis MurE inhibitors.</gtr:partnerContribution><gtr:piContribution>we supplied the structural information of ATP dependent MurE ligase from M. tuberculosis and the structures of MurE ligase inhibitors and theirs analogues.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Reversing antimicrobial resistance in TB</gtr:description><gtr:id>D3C533A0-6F28-4283-83D6-05E76B733653</gtr:id><gtr:impact>Two research articles published. One patent application submitted.</gtr:impact><gtr:outcomeId>56de758c9cb914.12482285-1</gtr:outcomeId><gtr:partnerContribution>Synthesis of novel chemical entities and their analogues.</gtr:partnerContribution><gtr:piContribution>Whole-cell phenotypic evaluation of novel chemical entities and target-based evaluation against recombinant proteins from Mycobacterium tuberculosis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Pharmacognosie Graz</gtr:department><gtr:description>Natural Product Chemistry_Austria (EU)</gtr:description><gtr:id>035290AF-CF57-496F-943E-03485BAAC29A</gtr:id><gtr:impact>A multi-disciplinary international collaboration (Natural Product Chemistry &amp;amp; Molecular Microbiology) generated the following outputs/ outcomes:

Original Research Articles:
1. Wube, A.; Guzman, J.D.; H&amp;uuml;fner, A.; Hochfellner, C.; Blunder, M.; Bauer, R.; Gibbons, S.; Bhakta, S. and Bucar, F. (2012) Synthesis and biological evaluation of a new series of N-alkyl-2-alkynyl-4-(1H)-quinolones. Molecules 17(7):8217-40.

2. Guzman. J-D.; Wube, A.; Evangelopoulos, D.; Gupta, A.; H&amp;uuml;fner, A.; Basavannacharya, C.; Raman, M. M.; Thomaschitz, C.; Bauer, R.; McHugh, T.D.; Nobeli, I.; Prieto, J. M.; Gibbons, S.; Bucar, F.; and Bhakta, S.* (2011) Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. J. Antimicrob. Chemotherapy 66(8):1766-72. 

3. Wube, A.; Guzman, J.D.; H&amp;uuml;fner, A.; Hochfellner, C.; Blunder, M.; Bauer, R.; Gibbons, S.; Bhakta, S. and Bucar, F. (2012) Synthesis and biological evaluation of a new series of N-alkyl-2-alkynyl-4-(1H)-quinolones. Molecules 17(7):8217-40.

Review Article:

Guzman, J.D.; Gupta, A.; Bucar, F.; Gibbons, S. and Bhakta, S.* (2012) Anti-mycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds. Frontiers in Bioscience 17, 1861-1881.

Joint Research Grant applications (successful):

1. Austrian Science Fund (FWF) 2012 - 2015 (?311K) Co-Apl [4-(1H)-Quinolone derivatives as new antibacterial drug-leads. Austrian Science Fund (FWF), EU]

2. Austrian Science Fund (FWF) 2008 - 2011 (?250K) Co-Apl [The evaluation of 4(1H)-quinolone derivatives as new anti-mycobacterial drug-leads. Austrian Science Fund (FWF): EU project P21152-B18]</gtr:impact><gtr:outcomeId>heF4AvaGB45-1</gtr:outcomeId><gtr:partnerContribution>Extract, fractionate, purify, semi-synthesize natural product inhibitors against whole cell mycobacteria as well as the target enzymes for validation.</gtr:partnerContribution><gtr:piContribution>Comprehensive evaluation of the biological properties of pure natural product compounds against the whole mycobacterial cell, drug efflux mechanisms and biofilm formation as well as against the target enzymes (ATP dependent mur ligases). Generated three joint research publications, a review article and a few others in preparation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Universiti Putra Malaysia</gtr:collaboratingOrganisation><gtr:country>Malaysia</gtr:country><gtr:description>Novel nano-particulate formulations to tackle MDR-TB_Malaysia</gtr:description><gtr:id>D6F39940-80F0-4A49-9D7A-452EDA84134F</gtr:id><gtr:impact>an original research article and an international research grant application are currently in preparation.</gtr:impact><gtr:outcomeId>58c6170317afc2.95523673-1</gtr:outcomeId><gtr:partnerContribution>Generated novel pharmaceutical formulations for testing their anti-TB properties and investigating anti-mycobacterial modes of action.</gtr:partnerContribution><gtr:piContribution>Comprehensive evaluation of biological properties of novel nano-particulate formulations against mycobacterial whole-cell, drug efflux mechanisms and biofilm inhibitions and a panel of endogenous targets.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Social Media Public Engagement</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0185B6BE-F721-4E01-A4EF-CE0785DF88F1</gtr:id><gtr:impact>620 people like the webpage and follow the posts, posts related to TB research and outreach activities reach about 1500 people every week.</gtr:impact><gtr:outcomeId>58c6251ed27976.24097860</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://www.facebook.com/TBrnotTB/</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Birkbeck School of Science Week 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9EBD0336-D605-4D0F-8E65-9EBE1B5DEA27</gtr:id><gtr:impact>Film screening and panel discussion: Tackling antibiotic resistance and the rise of superbugs at Birkbeck Cinema, 43 Gordon Square, London, WC1H 0PD 
Antibiotics were first mass-produced in the 1940s and their ability to fight and kill bacteria revolutionized medicine and profoundly impacted everything from agriculture to war. After less than 80 years, however, these miracle drugs are failing. Resistant infections kill hundreds of thousands of people around the world each year and there are now dozens of so-called Superbugs each with its own challenges and costs. How did this happen? Using microscopic footage, harrowing personal stories, and expert insights, Resistance clarifies the problem of antibiotic resistance, how we got to this point, and what we can do to turn the tide.</gtr:impact><gtr:outcomeId>58c622d4bda958.95812228</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbk.ac.uk/science/about-us/events/science-week/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>STEMNET/ Researcher in Residence (School Visit)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AE39DE42-9C32-4E03-9B2C-762022AB57EC</gtr:id><gtr:impact>A total of around 40 sixth formers and children on the Gifted and Talented Programme at St Mary's School, Bucks were learning about the germ that cause tuberculosis. I had been discussing my research on tuberculosis, and looking at how the disease is transmitted and spread, the rise of antibiotic resistance and the need to develop new drugs to combat the disease. The girls participated in a science club, combining scientific lectures with practical experience, for example on how to observe bacteria under a microscope, carried out observations, submitted practical reports and feedback on their findings. In addition I demonstrated the research methods we routinely use in the lab for determining whether any novel chemicals have medicine-like properties, using equipment from my laboratory, and a Science Technician from the named School, visited my lab to study the specific techniques used there prior to the school project.

The RinR programme has proved hugely popular with parents, teachers and pupils and the aim is to establish a longer term relationship between the School and the University, so that future generations of girls can be switched onto science.

Relevant Press Releases:
http://www.scienceoxfordnext.com/stem-news-articles/researcher-in-residence-switches-schoolgirls-onto-science; http://gerrardscross.buckinghamshireadvertiser.co.uk/2011/09/top-biologist-starts-residence.html; 
http://www.bbk.ac.uk/news/researcher-in-residence-switches-schoolgirls-onto-science; 
http://www.ps-magazine.co.uk/news.htm; http://www.stmarysschool.co.uk/news/RinRAutumn2011.htm</gtr:impact><gtr:outcomeId>MRN44yZALcF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.bbk.ac.uk/news/researcher-in-residence-switches-schoolgirls-onto-science</gtr:url><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WGND Interview (Podcast)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E44F4BCD-73DD-4320-8A90-2560E3545D24</gtr:id><gtr:impact>public interest and enquiris on the TB drug discovery research following the podcast.

Following the podcast interview:
(a) a local school showed interest developing a afterschool science club to perform some tests and discuss antibiotic resistance in TB.
(b) an international media enquired about new drug testing platform developed and possibility of using this technique in resource poor settings in India.</gtr:impact><gtr:outcomeId>M87ah9NNbDt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newtbdrugs.org/blog/podcast-interview-with-dr-sanjib-bhakta/</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture; article as part of a large Community Event</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70F8A0FE-7E80-4195-A200-35C0BAFAB802</gtr:id><gtr:impact>around 200 people attended the workshop, asked questions, discussion and feedback taken afterwards. 5000 printed copies of the published brochure was freely distributed to the public and also made available online to read.

awareness of Tuberculosis (TB) control strategies to the general public:
http://principlesofproteinstructure.blogspot.com/2011/04/structural-biology-in-fight-against-tb.html; http://www.tbd-uk.org.uk/news-items/world-tb-day-summary.html;</gtr:impact><gtr:outcomeId>n47gaJwTbGK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.londonsu.org/</gtr:url><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>After-School Science Project &quot;TB or not TB&quot;</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1B93F0D0-847C-4712-945E-3774D7E5094D</gtr:id><gtr:impact>Senior School girls engaged with an after school science club project entitled &amp;quot;TB or not TB&amp;quot;, visited local pharmacy to buy over the counter medicines for investigating their potential to be repurposed. Designed and performed wet-lab experiments, observed results, recorded data, presented report and a film to the public and British Institute of Technology and achieved &amp;quot;The most creative school award 2015&amp;quot; for the successful completion and execution of the science project. The award was formally collected from the House of Lords.</gtr:impact><gtr:outcomeId>56de79deaf9b05.16042571</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.bbk.ac.uk/news/tb-project-wins-bite-title</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World TB Day (Bloomsbury Public Event)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>242E127E-57C8-4B7A-949A-E5990384CC52</gtr:id><gtr:impact>series of public lectures, poster presentations, screening a film on TB awareness: &amp;quot;The Real Story&amp;quot; by TB Alert and panel discussions were enthusiastically attended by a housefull of 200 in the audience and participated in the questions and discussions throughout the day.

The event was supported and posted by a number of national and international TB organisations and charities. A large group of sixth form pupils attended the event and showed keen interest in the science activity.

Relevant Press Releases:
http://cms1.its.bbk.ac.uk/news/news-releases/world-tuberculosis-day
http://principlesofproteinstructure.blogspot.com/2011/04/structural-biology-in-fight-against-tb.html; http://www.tbd-uk.org.uk/news-items/world-tb-day-summary.html 

http://www.bbk.ac.uk/biology/about-us/oldevents/world-tuberculosis-day-2012 

http://www.worldtbday.org/idf-at-birkbeck/</gtr:impact><gtr:outcomeId>QDHohSBi5cX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>72000</gtr:amountPounds><gtr:country>Malaysia</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Graduate Research Scholarship</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Government of Malaysia</gtr:fundingOrg><gtr:id>FEC73B58-515E-49C6-83F0-35E0FBC75CCB</gtr:id><gtr:outcomeId>54609ff5bb71f3.15935963</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Birkbeck Translational Research Awards/Birkbeck University of London</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Birkbeck, University of London</gtr:fundingOrg><gtr:id>C4E4FB9A-3556-489B-A7CA-40C1C0F76240</gtr:id><gtr:outcomeId>piACiCeLATe0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UNESCO-Loreal Co-sponsored International Fellowship</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>United Nations Educational, Scientific and Cultural Organization (UNESCO)</gtr:fundingOrg><gtr:id>04B7091D-9726-44AF-86D7-B78AE75C2914</gtr:id><gtr:outcomeId>hmgwendf18a0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bloomsbury Graduate Scholarship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Birkbeck, University of London</gtr:fundingOrg><gtr:id>1C2D0835-5382-42CD-B788-90FC43D477E4</gtr:id><gtr:outcomeId>j51W3hJ8rrr0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Birkbeck Commercial Development Fund (Seed Fund)/ Birkbeck University of London</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Birkbeck, University of London</gtr:fundingOrg><gtr:id>EA8EE2AB-8FBE-4153-A91D-5CCE6C6426B8</gtr:id><gtr:outcomeId>nD41f45hpn80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/ Birkbeck Anniversary Graduate Research Scholarship</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7205E102-D378-4EC1-AA5B-CC5054697689</gtr:id><gtr:outcomeId>56de7713ee2f14.98964148</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Respiratory Society Short-term Research Fellowship</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>F77B3C51-5B49-497F-8689-FAA10F36992B</gtr:id><gtr:outcomeId>58c62061a51769.36111442</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Novel pyrroles have been designed, synthesized and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the anti-tubercular drugs BM212 1 and SQ109 2 that showed common chemical features with very similar topological distribution. A perfect superposition of the structures of 1 and 2 revealed by computational studies suggested the introduction of bulky substituents at the terminal portion of the pyrrole C3 side chain and the removal of the C5 aryl moiety. Five compounds showed high activity toward Mycobacterium tuberculosis, while 9b and 9c were highly active also against multi-drug resistant clinical isolates. Compound 9c showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In addition, four compounds showed potent inhibition (comparable to that of verapamil) towards the whole-cell drug efflux pump activity of mycobacteria, and thus turning to be promising multi-drug resistance reversal agents.</gtr:description><gtr:grantRef>G0801956</gtr:grantRef><gtr:id>43E2EEDB-1146-4121-8CC8-A98565DF33FD</gtr:id><gtr:impact>Potentially address the major health challenge globally to tackle the rise of antimicrobial resistance.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>56de7f5506ffc7.33510365</gtr:outcomeId><gtr:protection>Patent application published</gtr:protection><gtr:title>New antitubercular compounds</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A high-throughput (96 well format) non-radioactive biological assay for ATP-dependent Mur ligases from M. tuberculosis has been developed to determine the activity and/or inhibition of the target enzyme.</gtr:description><gtr:grantRef>G0801956</gtr:grantRef><gtr:id>5AA5EE55-22BE-469A-9AF9-F2BCF2C57803</gtr:id><gtr:impact>Availability of this assay is highly beneficial for TB inihibitor screening purposes and identifying novel mode of action for novel chemical entities. A number of academic research collaboration to be established on the basis of this facility.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>bzWLx8BHroJ</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>A high throughput assay for ATP dependent MurE ligase of Mycobacterium tuberculosis</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>new biologically active chemical entities with novel mechanisms of action as antimicrobials to tackle the drug resistance in infectious diseases primarily TB.</gtr:description><gtr:grantRef>G0801956</gtr:grantRef><gtr:id>BBA084A0-AB0D-4FDB-ABCC-96EECD8D6181</gtr:id><gtr:impact>Novel hits for anti-TB drug design.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>UEhjc9iAkPG</gtr:outcomeId><gtr:patentId>INSUFFICIENT INFORMATION</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>&amp;quot;Tetrahydroisoquinolines as Antimicrobials&amp;quot; (UCLB ref: 23-072)</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A solid culture based whole cell screening assay (HT-SPOTi; 24, 48 &amp;amp; 96 well format) to test libraries of inhibitors against the slow growing mycobacteria including Mycobacterium aurum and Mycobacterium tuberculosis.</gtr:description><gtr:grantRef>G0801956</gtr:grantRef><gtr:id>5343536B-BA3A-4AD2-B818-6524331E336F</gtr:id><gtr:impact>Availability of this whole cell screening assay is highly beneficial for TB inihibitor screening purposes. A large number of academic &amp;amp; industrial research collaborations to be established on the basis of this facility.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>noVPxqN1Dx1</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Whole cell screening of inhibitors against the growth of mycobacteria (HT-SPOTi)</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Future Science</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E615CC5B-EAA0-4409-82E7-1D5962A74487</gtr:id><gtr:outcomeId>CkRZthixr91</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://www.future-science.com/doi/full/10.4155/fmc.11.119</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Engaging local MP and a Member of House of Lords in TB control</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2570BCF-CA53-458D-9961-D8FBDD3D793D</gtr:id><gtr:outcomeId>BgvCnQcMudS</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Mentoring Session at INTERNATIONAL UNION on Antibitic Resistance in TB</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>79D0D4AE-C09C-4872-92F5-5CAB0C93BEA0</gtr:id><gtr:outcomeId>FXnaKvq6dyc</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.stoptb.org/assets/documents/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>This in vitro whole cell inhibitor screening model is developed for drug/ inhibitor screenig in an efficient and higher through put format. An UNESCO-Loreal International Fellowship is awarded to the research group to develop this model. Further support is required for the further development of this product.</gtr:description><gtr:id>C1325802-1547-4674-B01A-6DD925FE456C</gtr:id><gtr:impact>A large number of chemicals screened in rapid but for a gold standard output. A number of research collaborations and joint publications have arisen and a joint research grant application is under preparation.</gtr:impact><gtr:outcomeId>Qk4WEzSLkHN</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Whole cell assay for testing inhibitor and rapid daignosis of drug resistance profile</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693423/</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Studying molecular modes of anti-tubercular actions of NSAIDs.</gtr:description><gtr:id>F4D6FF6C-1039-486F-A65F-ACD3D41E8133</gtr:id><gtr:impact>Not applicable.</gtr:impact><gtr:outcomeId>ZscqVPZNimX</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Use of NSAIDs in novel anti-TB combination therapy</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693423/</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Rapid assay (HT-SPOT inhibition assay; 96 well) to test a large number inhibitors against the slow growing mycobacteria including M. tuberculosis.</gtr:description><gtr:id>E1A28ACD-4CEE-487B-9829-58EBC8974D40</gtr:id><gtr:impact>Interdisciplinary research collaboartion, a successful Austrian Research Fund Grant and a numeber of joint research publications.</gtr:impact><gtr:outcomeId>cWENjkrdtWM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Whole cell screening of inhibitors against the growth of mycobacteria (HT-SPOTi)</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://bmjopen.bmj.com/content/3/6/e002672.long</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A high-throughput (96 well plate based), non-radioactive biological assay for ATP-dependent Mur ligases (a validated target for novel anti-TB drugs) from Mycobacterium tuberculosis has been developed.</gtr:description><gtr:id>6D534659-C03C-4E2B-BB06-6CC86EAD6F6E</gtr:id><gtr:impact>Inter-disciplinary research collaborations</gtr:impact><gtr:outcomeId>tTArxQczXpN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High throught put enzyme assay for inhibitor screening</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060143</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Solved the structure of three mycobacterial proteins/ complexes and deposited to the protein databank (PDB: 2XW7, 2WTZ &amp;amp; 2XJA)</gtr:description><gtr:id>837ABF86-AEC5-41BE-A315-B90902CFF1C5</gtr:id><gtr:impact>Inter-disciplinary research collaboration. Initiation of designing specific small molecule inhibitors.</gtr:impact><gtr:outcomeId>UtiTPryYNE4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Deposition of 3D protein structural information to the Protein Data Bank</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid=2XW7</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1F526AF6-9357-4E49-858B-0011703AC774</gtr:id><gtr:title>Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/380577487a346b8bf6a00c43880b67f1"><gtr:id>380577487a346b8bf6a00c43880b67f1</gtr:id><gtr:otherNames>Scalacci N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0223-5234</gtr:issn><gtr:outcomeId>58c60e51422116.42033831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54FED0FC-49D2-4CCE-8C74-DA9A35E76380</gtr:id><gtr:title>Versatile routes to marine sponge metabolites through benzylidene rhodanines.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77dfe3df46d3fe140733e15f40cc675f"><gtr:id>77dfe3df46d3fe140733e15f40cc675f</gtr:id><gtr:otherNames>Kottakota SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>pm_14203_23_23234337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B436AD9-9010-4310-9F93-646AA99D5E5E</gtr:id><gtr:title>Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/139ab9dcd19be3881a221611eb975f4d"><gtr:id>139ab9dcd19be3881a221611eb975f4d</gtr:id><gtr:otherNames>Danquah CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa589c01b9f96.07768818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B60501B6-F5B8-40C9-B28F-91D7973A3498</gtr:id><gtr:title>Mycobacterium tuberculosis: immune evasion, latency and reactivation.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2647108e79ca174352f02bf675cba5e9"><gtr:id>2647108e79ca174352f02bf675cba5e9</gtr:id><gtr:otherNames>Gupta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>pm_14203_23_21813205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DA69C79-EA66-463A-A2F8-B5BEF0BB702B</gtr:id><gtr:title>Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef4886af58d356598faedafe2cb830d"><gtr:id>3ef4886af58d356598faedafe2cb830d</gtr:id><gtr:otherNames>Maitra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>58c60e51840ff0.74760464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7004C1F9-9D7B-4E58-BC21-6E17AFFE61C7</gtr:id><gtr:title>Antimycobacterials from lovage root (Ligusticum officinale Koch).</gtr:title><gtr:parentPublicationTitle>Phytotherapy research : PTR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c255ff65577bfc91cef459008b7f3237"><gtr:id>c255ff65577bfc91cef459008b7f3237</gtr:id><gtr:otherNames>Guzman JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0951-418X</gtr:issn><gtr:outcomeId>pm_14203_23_22899555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BFDC2BB-18BA-47C9-891A-5FDDB7090202</gtr:id><gtr:title>The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e125de461f095e9031ebb2c359cafc78"><gtr:id>e125de461f095e9031ebb2c359cafc78</gtr:id><gtr:otherNames>Phelan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58c60e51b275d5.10351488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CB32F53-ABEC-4F2B-AED3-CD53999065E1</gtr:id><gtr:title>HT-SPOTi: A Rapid Drug Susceptibility Test (DST) to Evaluate Antibiotic Resistance Profiles and Novel Chemicals for Anti-Infective Drug Discovery.</gtr:title><gtr:parentPublicationTitle>Current protocols in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/139ab9dcd19be3881a221611eb975f4d"><gtr:id>139ab9dcd19be3881a221611eb975f4d</gtr:id><gtr:otherNames>Danquah CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56de71c6f131e7.98956615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFE3EB53-4855-46B6-95D0-554592DEA7C1</gtr:id><gtr:title>Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c255ff65577bfc91cef459008b7f3237"><gtr:id>c255ff65577bfc91cef459008b7f3237</gtr:id><gtr:otherNames>Guzman JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>UzyDvFLwmjT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B54F61E2-5A5E-4762-BC88-18601B8F1228</gtr:id><gtr:title>Rapid methods for testing inhibitors of mycobacterial growth.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99e1ce46a078a2c54aa3362453f9805c"><gtr:id>99e1ce46a078a2c54aa3362453f9805c</gtr:id><gtr:otherNames>Evangelopoulos D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14203_23_20401596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEAA0AC2-7F71-4CC7-880D-9ECA75369705</gtr:id><gtr:title>A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>International journal of antimicrobial agents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6605ef80bc51a561996494b95215543"><gtr:id>f6605ef80bc51a561996494b95215543</gtr:id><gtr:otherNames>Shiu WK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0924-8579</gtr:issn><gtr:outcomeId>pm_14203_23_24119569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5983DA35-4284-4A91-9D84-CA85571F25BC</gtr:id><gtr:title>DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.</gtr:title><gtr:parentPublicationTitle>The Journal of antibiotics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d14bc18f2fcb286516c768464b9626c3"><gtr:id>d14bc18f2fcb286516c768464b9626c3</gtr:id><gtr:otherNames>Brucoli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-8820</gtr:issn><gtr:outcomeId>58c60e51e1bff9.52272219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CFD6E87-2E94-4D7F-B617-DFE7A20C0650</gtr:id><gtr:title>Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d14bc18f2fcb286516c768464b9626c3"><gtr:id>d14bc18f2fcb286516c768464b9626c3</gtr:id><gtr:otherNames>Brucoli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>56de71c8214db2.54445937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>775C150E-9CF5-4D2F-951C-BE5776D93E2E</gtr:id><gtr:title>An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>International journal of antimicrobial agents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/715aed8d675bff959a034a40272a64c8"><gtr:id>715aed8d675bff959a034a40272a64c8</gtr:id><gtr:otherNames>Osman K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0924-8579</gtr:issn><gtr:outcomeId>pm_14203_23_22079533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E56006E-FC94-46D7-ACE0-0B2862C4E802</gtr:id><gtr:title>Antimycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience (Landmark edition)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c255ff65577bfc91cef459008b7f3237"><gtr:id>c255ff65577bfc91cef459008b7f3237</gtr:id><gtr:otherNames>Guzman JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1093-4715</gtr:issn><gtr:outcomeId>pm_14203_23_22201841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE491C0F-826B-4047-BCDB-D43B259F19AD</gtr:id><gtr:title>Tackling tuberculosis: Insights from an international TB Summit in London.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef4886af58d356598faedafe2cb830d"><gtr:id>3ef4886af58d356598faedafe2cb830d</gtr:id><gtr:otherNames>Maitra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>56de71c7e8e615.83957077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>506A183A-1591-49AE-AC15-A1BCF4F5D29B</gtr:id><gtr:title>Essential residues for the enzyme activity of ATP-dependent MurE ligase from Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Protein &amp; cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c230ed5b13e3811e414934bcc85bd152"><gtr:id>c230ed5b13e3811e414934bcc85bd152</gtr:id><gtr:otherNames>Basavannacharya C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1674-800X</gtr:issn><gtr:outcomeId>sviYWSxun9J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB2D8485-5B6F-40F2-8548-2210EF72E378</gtr:id><gtr:title>The Properties of Solutions of Isoniazid in Water and Dimethylsulfoxide</gtr:title><gtr:parentPublicationTitle>Journal of Solution Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4a42a45eed2da89f7ab2ede802a9fd1"><gtr:id>b4a42a45eed2da89f7ab2ede802a9fd1</gtr:id><gtr:otherNames>Markarian S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_55f984984e5d0d59</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2B39245-6DB8-43A6-9815-C73687F7E850</gtr:id><gtr:title>Antioxidant, antitubercular and cytotoxic activities of Piper imperiale.</gtr:title><gtr:parentPublicationTitle>Molecules (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30fd13651a2968438cc31a34b3995d51"><gtr:id>30fd13651a2968438cc31a34b3995d51</gtr:id><gtr:otherNames>Diaz LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-3049</gtr:issn><gtr:outcomeId>pm_14203_23_22481537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6361721F-1347-4413-8939-753B61DB153C</gtr:id><gtr:title>Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2374b28debfd649e45516ae4aee17666"><gtr:id>2374b28debfd649e45516ae4aee17666</gtr:id><gtr:otherNames>Bhakta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56de71c77437e5.62307667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38ADF768-3874-4F74-BFCD-A2901F7676DE</gtr:id><gtr:title>Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c255ff65577bfc91cef459008b7f3237"><gtr:id>c255ff65577bfc91cef459008b7f3237</gtr:id><gtr:otherNames>Guzman JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5675df6f96241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48966B94-020F-46C9-A92B-F10836603F1B</gtr:id><gtr:title>Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99e1ce46a078a2c54aa3362453f9805c"><gtr:id>99e1ce46a078a2c54aa3362453f9805c</gtr:id><gtr:otherNames>Evangelopoulos D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>5460cb0cd6adc5.78150948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4FF6275-BC9D-43A4-A22C-7E5FF668C4E3</gtr:id><gtr:title>ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c230ed5b13e3811e414934bcc85bd152"><gtr:id>c230ed5b13e3811e414934bcc85bd152</gtr:id><gtr:otherNames>Basavannacharya C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>DJ4bEb8MPYf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2B578F4-BE08-4B64-B6E7-566922A26D36</gtr:id><gtr:title>Synthesis and biological evaluation of purpurealidin E-derived marine sponge metabolites: aplysamine-2, aplyzanzine A, and suberedamines A and B.</gtr:title><gtr:parentPublicationTitle>Journal of natural products</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77dfe3df46d3fe140733e15f40cc675f"><gtr:id>77dfe3df46d3fe140733e15f40cc675f</gtr:id><gtr:otherNames>Kottakota SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-3864</gtr:issn><gtr:outcomeId>pm_14203_23_22620987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27515297-8647-4EA1-A866-BDB88B07DA6D</gtr:id><gtr:title>Antimycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds</gtr:title><gtr:parentPublicationTitle>Frontiers in Bioscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42d0b336b5ea4cff2cd164dbf50afcb9"><gtr:id>42d0b336b5ea4cff2cd164dbf50afcb9</gtr:id><gtr:otherNames>Guzman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_55f984984e66b930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE13D314-EC32-436A-8EA7-AE2D00533CA7</gtr:id><gtr:title>Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c255ff65577bfc91cef459008b7f3237"><gtr:id>c255ff65577bfc91cef459008b7f3237</gtr:id><gtr:otherNames>Guzman JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>pm_14203_23_23794563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBC69E02-2EF8-4A34-81E8-F0FDF13A8929</gtr:id><gtr:title>Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones.</gtr:title><gtr:parentPublicationTitle>Molecules (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d9a71ba9d720cd42af2a61cf71184db"><gtr:id>2d9a71ba9d720cd42af2a61cf71184db</gtr:id><gtr:otherNames>Wube A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-3049</gtr:issn><gtr:outcomeId>pm_14203_23_22777190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D3A786A-EA32-4FAD-ACF3-106EB2FE39A5</gtr:id><gtr:title>An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2647108e79ca174352f02bf675cba5e9"><gtr:id>2647108e79ca174352f02bf675cba5e9</gtr:id><gtr:otherNames>Gupta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>pm_14203_23_22398649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30A12250-D48E-4236-9E62-5B4363148038</gtr:id><gtr:title>Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef4886af58d356598faedafe2cb830d"><gtr:id>3ef4886af58d356598faedafe2cb830d</gtr:id><gtr:otherNames>Maitra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>pm_14203_23_23863609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E460A9F-968E-4241-9028-9EDB4CCC579E</gtr:id><gtr:title>TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis-a meeting report of a Euroscicon conference.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef4886af58d356598faedafe2cb830d"><gtr:id>3ef4886af58d356598faedafe2cb830d</gtr:id><gtr:otherNames>Maitra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>5460790139b4d0.31540898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31B7A517-ACB2-4F98-8FF5-5B8428D5A681</gtr:id><gtr:title>Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e491e1bb172def39d0a494890df580a7"><gtr:id>e491e1bb172def39d0a494890df580a7</gtr:id><gtr:otherNames>Munshi T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14203_23_23555903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F8530E2-BF84-47DE-8114-DACBCB228C58</gtr:id><gtr:title>Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c255ff65577bfc91cef459008b7f3237"><gtr:id>c255ff65577bfc91cef459008b7f3237</gtr:id><gtr:otherNames>Guzman JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>T3MqzAE1iD2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801956</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>